Integrated Wealth Concepts’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Integrated Wealth Concepts's XBI Position: Q1 2026 in Review
Integrated Wealth Concepts increased its State Street SPDR S&P Biotech ETF (XBI) stake by 13% in Q1 2026, buying an estimated $353K and bringing the position to 24,565 shares worth $3.14M. The position accounts for 0.03% of the portfolio, ranked #588.
Integrated Wealth Concepts first reported a position in XBI in Q1 2020 and has held it in 25 quarters since. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- Integrated Wealth Concepts held 24,565 shares of State Street SPDR S&P Biotech ETF worth $3.14M as of Q1 2026.
- Integrated Wealth Concepts bought 2,830 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $353K.
- State Street SPDR S&P Biotech ETF made up 0.03% of Integrated Wealth Concepts's portfolio in Q1 2026, its #588 holding.
- Integrated Wealth Concepts first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 25 quarters since.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.